Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1726 - 1750 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Pentaacylaminosugars LMSL01050004
  • Rhodobacter sphaeroides Lipid A
171121060 1526.927134 C76H140N2O24P2
Diacylglycerophosphoinositolglycans LMGP15010228
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:0/18:0)
126457596 1690.868208 C76H139O38P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN04
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260271 1593.922944 C76H139NO33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC05
  • Forssman antigen(d18:1/24:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260184 1541.954517 C76H139N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD05
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Para-Forssman x3b(d18:1/24:0)
44260192 1541.954517 C76H139N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BC05
  • GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260392 1541.954517 C76H139N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BD05
  • GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260400 1541.954517 C76H139N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AC05
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260504 1541.954517 C76H139N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AE05
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260520 1541.954517 C76H139N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AO05
  • GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260600 1541.954517 C76H139N3O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AJ05
  • GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260688 1541.954517 C76H139N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK05
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • nLc5Cer(d18:1/24:0)
44261056 1541.954517 C76H139N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BN05
  • GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • P antigen(d18:1/24:0)
44261288 1541.954517 C76H139N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CE05
  • GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261424 1541.954517 C76H139N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD05
  • Forssman-like iGb4(d18:1/24:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261864 1541.954517 C76H139N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AO05
  • GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261928 1541.954517 C76H139N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BG05
  • GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261680 1541.954517 C76H139N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ03
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260294 1606.918193 C76H138N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF03
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260414 1606.918193 C76H138N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA03
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261630 1606.918193 C76H138N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI03
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type IV H(d18:1/20:0)
44260230 1590.923278 C76H138N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BM03
  • Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260470 1590.923278 C76H138N2O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AK03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260566 1590.923278 C76H138N2O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type I B antigen(d18:1/20:0)
44260646 1590.923278 C76H138N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type II B antigen(d18:1/20:0)
44261006 1590.923278 C76H138N2O32

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024